ELGX, Endologix Inc.

STDF, Steadfast Holdings Group Inc, STDF.PK

PennyOmega.com Watch List!

PennyOmega.com Watch List ! for Thursday July 23, 2009

Our Picks at PennyOmega.com for Thursday July 23, 2009, are:

**************************************************************

STDF, Steadfast Holdings Group, Inc., STDF.PK

STDF distributes green products to the housing markets and a variety of products to the automotive aftermarket.

**To consider about STDF:

Today, STDF Subsidiary Lands $28.6 Million Building Contract

STDF through its Banx and Green Group, Inc. subsidiary has completed a contract to build a minimum of 11 Emergi-Care centers with in house diagnostic equipment for health care providers on the West Coast. The emergence of a shift in medical care for the uninsured away from emergency room medicine fuels

...

For Immediate Release

Chicago, IL - April 27, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Lockheed Martin Corp (LMT), Schlumberger, Ltd. (SLB), Halliburton's (HAL), deCODE genetics, Inc. (DCGN) and Celera Corp. (CRA).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Friday's Analyst Blog:

Lockheed Beats & Ups Guidance

Lockheed Martin Corp (LMT) reported a 1st quarter 2009 profit of $666 million, down 9% from $730 million in the 1st quarter of 2008.

On a per-share basis, the reported result was $1.68 per diluted share, down 4% from $1.75 per diluted share

...

 Yesterday (Thursday), deCODE genetics, Inc. (DCGN) announced that the company signed an agreement with Celera Corp. (CRA). Pursuant to the agreement, deCODE granted Celera non-exclusive worldwide licenses to deCODE's genetic markers for increased risk of major cardiovascular and metabolic diseases, including heart attack, stroke, atrial fibrillation (AF) and type II diabetes. These markers can be incorporated into laboratory tests for assessing and managing individual risk of these diseases.The deCODE markers include single letter variations in the human genome (SNPs) on chromosome 9p21 linked to increased risk of heart attack and aortic aneurysm, SNPs on chromosome 4q25 conferring risk of AF and stroke, and SNPs in the TCF7L2 gene linked to increased risk of type II diabetes. Studies by deCODE and independent academic groups have demonstrated the utility of testing for these markers to better understand individual risk and to inform more effective and personalized prevention ...

Abdominal Aortic Aneurysms (AAA) is an aneurysm caused from a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a leading cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA. The overall patient mortality rate for ruptured AAA is approximately 75%.

IntuiTrak has a novel design and deployment mechanism that simplifies delivery of the unibody bifurcated Powerlink device. The low-profile delivery system features enhanced flexibility, advanced hemostasis control and a hydrophilic coating to facilitate smooth delivery, particularly in patients with limited or difficult vascular access. Additionally, the delivery catheter has an integrated sheath to facilitate introduction. This feature avoids the need for exchanges, thereby having the potential to reduce procedure time, blood loss and minimize

...